Tissue Genesis Introduces State-of-the-Art Icellator® X

The enhanced enzyme-derived stem cell isolation system offers a greater overall impact and efficiency in the field of regenerative medicine

Houston (December 11, 2018) – Tissue Genesis LLC announced today the release of the Icellator® X, the newest and most advanced system for isolating stem cells in adipose tissue.

The Icellator® X expands on the capabilities of the original Icellator®, representing a major advancement in the real-world application of stem therapies for patients.

The new-to-market Icellator® X offers greater stem cell yields, improved ease of use, and a user interface available in multiple languages. It is immediately the most efficient system available on the market. The 2019 Icellator® X lets medical professionals and scientists rapidly recover millions of a patient’s own adult stem cells for therapeutic treatments and research applications.

Leer más

TG y Human Life CORD de Japón anuncian una alianza exclusiva

HOUSTON (Nov. 1, 2017) – Human Life CORD Japan, Inc., (HLC), una empresa del grupo Nihon Trim (N.º de identificación 6788 del primer mercado de la Bolsa de Valores de Tokio) se complace en anunciar un acuerdo estratégico con Tissue Genesis, LLC (TG) para distribuir sus productos patentados de procesamiento de células madre en clínicas comerciales, centros de investigación y hospitales de Japón y China. Leer más